Tissue sample preparation in CMP - Dipa Begum & Susie Riisnaes

News & events

  • 04 October 2021
    A Novel Solution

    Research funded by the NIHR Biomedical Research Centre (BRC) at The Royal Marsden and The Institute of Cancer Research, London (ICR) and pharmaceutical company Kortuc is investigating whether the common antiseptic hydrogen peroxide can enhance the cancer-killing effects of radiotherapy in breast cancer patients.

  • 02 October 2021
    Presenting Progress

    In June, experts from The Royal Marsden presented the results of their pioneering research to a global online audience at the American Society of Clinical Oncology (ASCO) Annual Meeting, the world’s largest cancer conference

  • 01 October 2021
    Brain cancer breakthrough

    Combining Immunotherapy with an experimental cancer drug could offer a new way of treating some patients with aggressive brain cancers, according to early results from the Phase 1 Ice-CAP trial, led by researchers from The Institute of Cancer Research, London, and The Royal Marsden.

  • 05 April 2021
    Drug Discovery in Action

    Read about three trials of exciting new cancer drugs that demonstrate the joint ‘bench to bedside’ approach of The Royal Marsden and the ICR.

  • 01 April 2021
    Q&A: Professor Vinidh Paleri

    The Consultant Head and Neck Surgeon at The Royal Marsden and Director of the new International Centre for Recurrent Head & Neck Cancer (IReC) explains the centre’s aims.

  • 27 January 2020
    Supporting specialists

    Through the Molecular Pathology Starter Programme, the NIHR BRC is training new scientists in the latest diagnostic techniques

  • 15 January 2020
    Blood will tell

    Blood tests known as ‘liquid biopsies’ could represent a major step forward in our ability to detect and monitor breast and other cancers

  • 19 December 2019
    Professor Nandita deSouza

    Professor of Translational Imaging at the ICR

  • 10 December 2019
    Time to work smarter

    A new approach to clinical trials can help us get novel drugs to patients faster, says Professor Christina Yap, Team Leader in the ICR’s Clinical Trials and Statistics Unit

  • 05 December 2019
    Dr Katharina von Loga

    Consultant Molecular Pathologist at The Royal Marsden

Previous